Tradestie Institutional Equity Comparison Engine

BNZI vs MAIA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

MAIA Overall Edge

MAIA Captures Institutional Edge (3โ€“0 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to MAIA Biotechnology, Inc. (MAIA) driven by superior Valuation, Growth & Margin, Momentum & Technical. Fundamentally, BNZI trades at N/M Forward P/E with -214.4% operating margin (-20.2% YoY revenue) versus MAIA at 1.2x Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, BNZI sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against MAIA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner MAIA
BNZI N/M vs MAIA 1.2x Fwd P/E
Growth & Margin Winner MAIA
Op Margin -214.4% vs 0.0% ยท YoY -20.2% vs +0.0%
Momentum & Technical Winner MAIA
1Y -40.3% vs +20.6% ยท 52W Pos 21% vs 10%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
BNZI NASDAQ
Banzai International, Inc. Class A Common Stock
Services-Prepackaged Software
$1.91
+7.91% 1D
Market Cap $5.9M
1M Return -37.17%
1Y Return -40.31%
Forward P/E N/M
Unified AI Score
48.9 / 100 HOLD
Tech 25.0 Fund 43.0 Flow 50.0 Mom 60.0
MAIA NYSE American
MAIA Biotechnology, Inc.
Pharmaceutical Preparations
$1.11
-2.63% 1D
Market Cap $68.5M
1M Return -1.77%
1Y Return +20.65%
Forward P/E 1.2x
Unified AI Score
37.6 / 100 SELL
Tech 40.0 Fund 38.0 Flow 50.0 Mom 44.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BNZI -40.31% MAIA +20.65% Spread: +3.5 pp (BNZI Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
BNZI TTM Op. Margin: -214.4% MAIA TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BNZI vs MAIA. Trailing 12-month operating profitability (BNZI -214.4% vs MAIA 0.0%) and valuation multiples (BNZI N/M vs MAIA 1.2x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BNZI (3) vs MAIA (7)
Institutional Metric BNZI MAIA Criterion Row Winner
Market Capitalization Scale $5.9M $68.5M Larger Scale MAIA
Trailing P/E Ratio Valuation 0.0x 1.2x Lower Multiple BNZI
Forward P/E Ratio Valuation N/M 1.2x Lower Multiple MAIA
Revenue Growth (YoY) Growth -20.2% +0.0% Higher Growth MAIA
Operating Margin (TTM) Profitability -214.4% 0.0% Higher Margin MAIA
Net Profit Margin Profitability -237.5% 0.0% Higher Margin MAIA
Return on Equity (ROE) Capital Efficiency -493.9% -341.5% Higher ROE MAIA
52-Week Range Position Momentum 21% ($0โ€“$8) 10% ($1โ€“$3) Stronger Trend BNZI
Beta / 30D Volatility Risk Regime 12.28ฮฒ ยท 134% Vol 1.65ฮฒ ยท 108% Vol Lower Realized Risk MAIA
Unified Institutional Score Composite Signal 48.9 / 100 (HOLD) 37.6 / 100 (SELL) Higher Composite BNZI

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BNZI vs MAIA Buy Guide
BNZI UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BNZI Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
MAIA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live MAIA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BNZI nor MAIA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.